"Cell Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
| Descriptor ID |
D002470
|
| MeSH Number(s) |
G04.346
|
| Concept/Terms |
Cell Survival- Cell Survival
- Survival, Cell
- Cell Viability
- Cell Viabilities
- Viabilities, Cell
- Viability, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Survival".
Below are MeSH descriptors whose meaning is more specific than "Cell Survival".
This graph shows the total number of publications written about "Cell Survival" by people in this website by year, and whether "Cell Survival" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 39 | 41 |
| 1996 | 3 | 53 | 56 |
| 1997 | 3 | 45 | 48 |
| 1998 | 1 | 66 | 67 |
| 1999 | 4 | 58 | 62 |
| 2000 | 1 | 86 | 87 |
| 2001 | 10 | 98 | 108 |
| 2002 | 10 | 118 | 128 |
| 2003 | 14 | 162 | 176 |
| 2004 | 14 | 144 | 158 |
| 2005 | 11 | 159 | 170 |
| 2006 | 7 | 169 | 176 |
| 2007 | 7 | 170 | 177 |
| 2008 | 12 | 188 | 200 |
| 2009 | 12 | 195 | 207 |
| 2010 | 10 | 208 | 218 |
| 2011 | 17 | 212 | 229 |
| 2012 | 8 | 209 | 217 |
| 2013 | 14 | 228 | 242 |
| 2014 | 12 | 214 | 226 |
| 2015 | 9 | 217 | 226 |
| 2016 | 7 | 183 | 190 |
| 2017 | 9 | 153 | 162 |
| 2018 | 5 | 133 | 138 |
| 2019 | 6 | 163 | 169 |
| 2020 | 8 | 133 | 141 |
| 2021 | 4 | 89 | 93 |
| 2022 | 2 | 12 | 14 |
| 2023 | 0 | 12 | 12 |
| 2024 | 7 | 31 | 38 |
| 2025 | 0 | 6 | 6 |
Below are the most recent publications written about "Cell Survival" by people in Profiles.
-
Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells. Sci Rep. 2025 Feb 17; 15(1):5749.
-
Recombinant Methioninase (rMETase) Synergistically Sensitizes Ivermectin-resistant MCF-7 Breast Cancer Cells 9.9 Fold to Low-dose Ivermectin. Anticancer Res. 2025 Feb; 45(2):451-455.
-
The X-Linked Tumor Suppressor TSPX Regulates Genes Involved in the EGFR Signaling Pathway and Cell Viability to Suppress Lung Adenocarcinoma. Genes (Basel). 2025 Jan 11; 16(1).
-
Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A2 α for targeted cancer therapy. Nat Commun. 2025 Jan 02; 16(1):164.
-
Ivermectin Combined With Recombinant Methioninase (rMETase) Synergistically Eradicates MiaPaCa-2 Pancreatic Cancer Cells. Anticancer Res. 2025 Jan; 45(1):97-103.
-
Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models. In Vivo. 2025 Jan-Feb; 39(1):120-126.
-
Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma. Cancer Res Commun. 2024 12 01; 4(12):3165-3179.
-
Long-Circulating and Targeted Liposomes Co-loading Cisplatin and Mifamurtide: Formulation and Delivery in Osteosarcoma Cells. AAPS PharmSciTech. 2024 Nov 26; 25(8):272.
-
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time. Cancer Genomics Proteomics. 2024 Nov-Dec; 21(6):585-590.
-
BiP/GRP78 is a pro-viral factor for diverse dsDNA viruses that promotes the survival and proliferation of cells upon KSHV infection. PLoS Pathog. 2024 Oct; 20(10):e1012660.